era-coda study: overview, first results & what we can learn from different approaches on covid-19
Published 3 years ago • 350 plays • Length 1:01:55Download video MP4
Download video MP3
Similar videos
-
1:15:13
kidney related aspects of covid-19 - eracoda e-seminars series #2
-
1:01:52
kidney related aspects of covid-19 - eracoda e-seminars series #1
-
1:02:19
covid-19 vaccines, drugs, ongoing trials, how far have we come
-
27:00
coronavirus pandemic update 58: testing; causes of hypoxemia in covid-19 (v/q vs shunt vs diffusion)
-
1:33:18
covid-19 clinical updates & lessons learned so far with dr. roger seheult - live webcast replay
-
32:34
inside tan tock seng hospital's fight against the covid-19 pandemic
-
47:36
meet the virus hunters: before the next pandemic strikes | disease hunters | part 1/3
-
9:09
how corona virus affects your body? | covid-19 | the dr binocs show | peekaboo kidz
-
15:32
coronavirus pandemic update 93: antibodies, immunity, & prevalence of covid-19 - new data from spain
-
1:44:31
monitoring universal health in the era of covid-19 audio english
-
59:45
expanding the patient's voice in nephrology with patient outcome measures
-
2:05:13
new national data models show slower spread of covid-19
-
1:16:38
the continuing covid-19 pandemic: current issues and glimpse into the future
-
3:26
covid-19: understanding your results
-
3:22
mayo clinic insights: what is a covid-19 variant strain
-
1:34:25
comprehensive covid-19 (coronavirus disease): emerging data and guidance on diagnosis and management
-
1:37:42
health canada releases covid-19 modelling | special coverage
-
15:47
coronavirus pandemic update 54: covid-19 antibody vs. pcr testing; when to relax social distancing?
-
7:46
coronavirus pandemic update 49: new data on covid-19 vs other viral infections (ventilator outcomes)
-
26:49
long-term evolution of long covid - roger paredes, md, phd
-
52:38
long covid: risk factors, symptomology and pros captured through a novel digital platform
-
10:31
coronavirus pandemic update 39: rapid covid-19 spread with mild or no symptoms, more on treatment